Central Nervous System Tumors Clinical Trial
Official title:
A Study of Late Effects After Proton Radiotherapy for Pediatric Tumors of the Brain, Head, and Neck
The purpose of this study is to collect information from medical records to see what effects proton beam radiation has on cancer and analyze possible side effects.
Data collection will be obtained from the patient's medical records including initial evaluation, radiotherapy completion records and follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00876993 -
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
|
Phase 1 | |
Completed |
NCT00003935 -
Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
|
Phase 1 | |
Terminated |
NCT00107471 -
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
|
Phase 1/Phase 2 | |
Completed |
NCT00003573 -
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
|
Phase 2 | |
Recruiting |
NCT05235074 -
OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
|
Phase 1/Phase 2 | |
Suspended |
NCT05308407 -
POWER UP: Participating Online While Exercising to Recover Using Play
|
N/A | |
Terminated |
NCT00477503 -
Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA
|
Phase 1 | |
Active, not recruiting |
NCT01985451 -
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)
|
Phase 2 | |
Withdrawn |
NCT00109798 -
Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
|
N/A | |
Completed |
NCT00003203 -
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
|
Phase 2 | |
Completed |
NCT00003141 -
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
|
Phase 1 | |
Completed |
NCT02462629 -
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
|
Phase 1 | |
Active, not recruiting |
NCT01735747 -
Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma
|
Phase 2 | |
Recruiting |
NCT00607984 -
Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors
|
N/A | |
Completed |
NCT00899834 -
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
|
N/A | |
Completed |
NCT00066248 -
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
|
Phase 2 | |
Completed |
NCT00187226 -
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
|
Phase 2 | |
Completed |
NCT02793466 -
Durvalumab in Pediatric and Adolescent Patients
|
Phase 1 | |
Withdrawn |
NCT01052363 -
OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas
|
Phase 1 | |
Completed |
NCT00047320 -
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
|
Phase 2 |